KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.5500
-0.0100 (-1.79%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.5600
Open0.5600
Bid0.5500 x 0
Ask0.5600 x 0
Day's Range0.5500 - 0.5700
52 Week Range0.5500 - 4.2600
Volume498,348
Avg. Volume423,112
Market Cap64.137M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • CNW Group

    Khiron Granted Approval to Cultivate 9.3 Tons of THC Cannabis, Representing 17% of the Total Allocated Quota for Colombia in 2020

    Colombia was granted a total production quota of 56.2 tons of medical cannabis for 2020 by the International Narcotics Control Board ("INCB"), the entity responsible for the implementation of the United Nations drug conventions. This represents 21.9% of the world´s legal global supply of high THC medical cannabis. The Company will begin cultivation activities immediately in its existing state-of-the-art facility near Ibague, Colombia , with its already-registered strains.

  • CNW Group

    Khiron Announces Plans to Expand Kuida® Distribution to Spain

    Company prepares to bring Kuida CBD brand to Spain with receipt of "no objection" letter from TSXV, subject to complying with all regulatory requirements in Spain As previously announced, Khiron ...

  • CNW Group

    Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC

    TORONTO, Feb. 14, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce it will be participating in the 3rd Annual Gravitas Growth Conference taking place February 20th, 2020 at the Fairmont Pacific Rim Hotel in Vancouver, BC. Mr. Naprawa will also host individual investor meetings on February 20th at this year's Gravitas Growth Conference, which will feature approximately 20 companies and will be attended by over 250 individuals.

  • CNW Group

    Khiron Announces Normal Course Issuer Bid

    TORONTO , Feb. 11, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF) (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , announces today its intention to commence a normal course issuer bid through the facilities of the TSX Venture Exchange (the "TSXV") to repurchase, for cancellation, up to 5,830,615 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstanding Shares (the "NCIB").

  • CNW Group

    Khiron to Host Investor Webcast Live on February 11, 2020

    TORONTO, Feb. 10, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce that Chris Naprawa, President, will present live at Grit Capital's Webcast Series on February 11th, 2020 at 11:00am ET/8:00am PT.

  • CNW Group

    Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product

    Authorization from the Brazilian Health Regulatory Agency (ANVISA) allows for Khiron medical cannabis product to be imported for use on an individual patient basis Authorization follows December 2019 announcement ...

  • Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic
    CNW Group

    Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic

    Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic

  • CNW Group

    Khiron CEO Alvaro Torres to Present at AltaCorp/ATB 8th Annual Institutional Investor Conference

    TORONTO, Jan. 6, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that CEO and Director Alvaro Torres will speak on the International Expansion panel at the AltaCorp/ATB 8th Annual Institutional Investor Conference at 3:10pm on January 14, 2020. Mr. Torres and other members of the Khiron leadership team will also be conducting one-on-one meetings at the conference, taking place January 14-16, 2020 at the Shangri-La Hotel Toronto.

  • CNW Group

    Khiron Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis

    Khiron the only LP with a 2019 quota that authorizes the Company to manufacture high-THC whole plant extract and produce customized medical cannabis prescriptions for domestic use 56.5 tons, or 21.84% ...

  • CNW Group

    Khiron Welcomes Regulatory Guidelines in Peru, Announces Good Storage Practices Certification

    Peruvian authorities to allow businesses to begin applications for medical cannabis licenses, and further outline a clear licensing process Khiron has secured Good Storage Practices (GSP) certification, ...

  • CNW Group

    Khiron Welcomes Legalization of Medical Cannabis in Brazil

    Khiron Welcomes Legalization of Medical Cannabis in Brazil

  • CNW Group

    Khiron Announces Chairman Transition and Appointment of Audit Committee Chair

    TORONTO , Nov. 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , today announced that Sidney Himmel has resigned as Director and Chair of the Board to pursue other interests, effective immediately. "On behalf of my fellow directors, the Company's management team, and shareholders we thank Sid for his many contributions to Khiron since its founding," said Alvaro Torres , Khiron's CEO and Director.

  • CNW Group

    Khiron Announces Option and Restricted Share Unit Grants

    TORONTO, Nov. 27, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced that it has granted stock options and restricted share units (RSUs) to certain directors and officers of the Company and its subsidiaries under the Company's Amended and Restated Stock Option Plan and Amended and Restated RSU Plan. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America.